BTC $ 8,794.97 0.38645%
ETH $ 186.67 0.392008%
MARKET CAP $ -100%
ICOs 5,550

Stem Cell

ICO Ended
9,309 Views
At SCI, we are devoted to the international research, development, and implementation of stem cell therapy. We are also expanding our network with professionals, labs, clinics, hospitals, and nonprofit organizations. Our ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. At SCI, we believe such connections should be convenient and at your fingertips, just as so many other services are in modern society. We imagine a world where each and every person, no matter where they come from, will be able to connect with a Stem Cel Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.
8.8
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

9
SOCIAL ACTIVITY

(weight: 35%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 17 Sept 2018 - 09 Oct 2018
ICO Time: 21 Nov 2018 - 17 Jan 2019
Whitelist/KYC: KYC
Country: Gibraltar
Token info
Ticker: SCI
Platform: Ethereum
Token Type: ERC20
Available for sale: 800,000,000 SCI
Financial
ICO Price: 1 SCI = 0.15 USD
Accepting: BTC, ETH, LTC, Fiat
Soft cap: 3,000,000 USD
Hard cap: 36,000,000 USD
2013
Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.
Q4 2017
Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.

Advanced research begins to determine market and development opportunities.
Q1 2018
Attended Token 2049 conference in Hong Kong.

Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).

Attended CBC conference in San Francisco, CA.
Q2 2018
Attended ICO20 Summit in Santa Monica, CA.

Integration of smart contract technology is established.

Company headquarters incorporated in Gibraltar, GB.

Strategic efforts toward development begins.

Interviews with potential medical participants take place.
Q3 2018
Whitelist is scheduled to go live.

Token Sale starts.
Q4 2018
Token Sale ends and min max caps are assessed.

Distribution of Tokens to participants through ERC20 will commence.
Q1 2019
SCI will begin final testing and reporting based on blockchain technology being used.

Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.

Demo testing for SCI Application v 1.0 will begin.
Q2 2019
Release of the SCI Application v1.1

Enrollment begins for doctors, patients, and stem cell laboratories in the United States
Q3 2019
Release of Market Surveillance strategy for further growth

Release SCI Application v2.0

Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.

Announcement of first SCI Lab location and franchise expansion plan.
Q4 2019
Announcement of clinical development and research strategy in the stem cell field.

Public announcement regarding SCI achievements to date.

First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.
Q1 2020
Stem Cell Lab Evaluation report per first year of operation and development.

Release SCI earnings and financials report.

Release results of SCI's stem cell research and development to date.
Q2 2020
Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.

Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.
Q3 2020
Begin second phase of SCI stem cell research and development.

Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.
Q4 2020
Expansion and acquisition of SCI stem cell labs and clinics in Europe.
Q1 2021
Release SCI earnings and financials report for second year operation and development.

Release public update on SCI stem cell research and development.

Stem Cell Lab Evaluation report for second year.
Q2 2021
Release SCI Application v4.0 including:

A new platform for medical students, universities, and hospitals to engage with the SCI Application.

Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.
Screenshots taken 13 Sep 2018
Moe Galal
Chief Executive Officer / Founder
Takes part in this project only
Ben Barel
Chief Operations Officer / Co-Founder
Takes part in this project only
Ali Alrashidi
Chief Technology Officer / Co-Founder
Takes part in this project only
Matt Galal
Chief of Staff / Co-Founder
Takes part in this project only
Kobi Barel
Operations Engineer / Co-Founder
Takes part in this project only
John Glavinovich, M.D.
Medical Director
Takes part in this project only
Philip Glukhovsky, D.C.
Health Informatics Manager
Takes part in this project only
Roger Williams
VP of Marketing
Takes part in this project only
Liz Curlett
VP, PR & Corporate Communications
Takes part in this project only
Candice Kouchache
Business Development
Takes part in this project only
Ahmed Elsantawi
VP of International Human Resources
Takes part in this project only
David Marmon
Web Designer
Takes part in this project only
Heather Deveaux
Copywriter
Takes part in this project only
Everlecia Taylor
Creative Writer
Takes part in this project only
Marina Evglevskaya
Administrative Manager
Takes part in this project only
Rakel Apodaca
Product Manager
Takes part in this project only
Michelle Chavon
Marketing
Takes part in this project only

Advisors (7)

Boyan Josic
Participates in a number of projects
Marc X. Ellul
Participates in several projects
Roger Shortz, M.D.
Takes part in this project only
Greg Maddex, D.O
Takes part in this project only
Pantea Nakieen, M.D.
Takes part in this project only
Shahab Sajadi
Takes part in this project only
Igor Soshkin
Participates in several projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Pre-Sale
NiMEDix ecosystem
NiMEDix ecosystem is the much-needed disruptive solution in the African Health Industry. It is a unique medical ecosystem designed to decentralize the health sector in Africa using Artifcial intelligence (machine learning) and the blockchain as a tool to disrupt and provide accessible, quality and adordable health care. NiMEDix allows direct interaction among consumers, insurers and service providers to improve health care access, reduce costs and streamline payments, regardless of whether it’s a patient, employer, insurer or government agency making a healthcare payment. We are seeking to improve care outcomes through effective coordination and eliminate much of the cost of redundancy, inefficient administrative policies, waste, abuse and fraud from the system.
Active
Zillios
Zillios is the next generation international real estate platform, revolutionary and highly innovative. Zillios completely changes the way the real estate market operates providing a state of the art scalable infrastructure to all key stakeholders, including smart contract based features to tackle current inefficiencies in rental and buying processes. Blockchain-based property transfer is foreseen in Zillios´ technology providing a future-proof infrastructure.
Upcoming
Aluna.Social
Aluna.Social is a multi-exchange social trading terminal for cryptocurrency traders and investors. We combine a social network with an API trading platform integrated with top crypto exchanges, enabling copy trading features and public profiles featuring unforgeable trading performance and history.
Upcoming
Minerva
Minerva is the world's first reverse merchant processor. We pay transaction fees to approved businesses integrated within the Minerva economy, we don't charge them. Minerva is a platform designed to incentivize the adoption of its OWL token with a new and disruptive economic model.
Active
Fieldcoin
Fieldcoin is disrupting a market of more than 10 trillions USD, enabling everyone to own and manage farmland from distance. Agricultural land is the most stable asset of all over the last decades. Fieldcoin tokens contrast with other utility tokens in providing a Trade Back rate on the Fieldcoin platform stabilizing its price during bear markets. When holding Fieldcoin tokens, you will not only be able to buy, sell and manage real land properties in the form of non-fungible tokens, but also access full ownership and control over the production by tracing all the levels of inputs and outputs of chemicals applied to your soil. This platform will be build for the people, empowering everyone on Earth with land ownership rights. During the FCO (Field Coin Offering) users will already be able to buy land properties with their tokens. In exchange for their Ethers, Bitcoins and Fieldcoins, holders will receive LANDS non-fungible tokens (ERC721) representing an agricultural land.
Upcoming
REPU
The REPU system (abbreviated from English – "reputation") is a revolutionary project that allows you to completely rethink the way social networks are perceived. REPU is a rating and feedback system based on decentralized blockchain technology. Technology allows you to completely replace the system of “likes” with the rating - both for users and for companies. The rating, subsequently, can be used as an assessment tool in various areas of the individual’s life - starting with professional skills, financial stability, and ending with all possible aspects of behavior and interaction with the public.